Poland· PL-100182587
IPP 20
A pantoprazole product containing pantoprazolum, registered in Poland by Sandoz GmbH. The same ATC class is registered in 18 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Pantoprazole is registered in 18 of 19 countries.
Countries holding a registration under ATC A02BC02 (pantoprazole), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Pantoprazole · ATC A02BC02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pantoprazole costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.14 in France to $0.65 in Switzerland — a ×4.8 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pantoprazole · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.65
- ES Spain$0.36
- IT Italy$0.24
- FR France$0.14
The record
At a glance
URPL (Poland)- Active substance
- Pantoprazolum
- Manufacturer
- Sandoz GmbH
- Country
- Poland (PL)
- ATC code
- A02BC02
- ATC class
- Pantoprazole
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 8
1 priced- gtin0590999008503328 szt.PLN 10.01
- gtin05909990084999
- gtin05909990085002
- gtin05909990085026
- gtin05909990664283
- gtin05909990817542
- gtin05907626701791
- gtin05907626702323
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
720 interactions on record for pantoprazole.
Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pantoprazole · interactions on record
720 records
- 21 severe
- 115 moderate
- 30 minor
- 545 info
Most severe, free to view
- NelfinavirJ05AE04severe
- AtazanavirJ05AE08severe
- RilpivirineJ05AG05severe
- Sofosbuvir and velpatasvirJ05AP55severe
9 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A02BC02
Pantoprazole, as other registers publish it.
- SwitzerlandAcido-X, magensaftresistente Tablettenaxapharm ag
- SwitzerlandAcido-X, magensaftresistente Tablettenaxapharm ag
- CanadaAG-PANTOPRAZOLE SODIUMANGITA PHARMA INC.
- NetherlandsAlbert Heijn Maagzuurremmende tabletten Pantoprazol 20 mg, maagsapresistente tablettenHealthypharm B.V.
- SwitzerlandAmavita Pantoprazol 20 mg, magensaftresistente TablettenAmavita Health Care AG
- SwitzerlandAmavita Pantoprazol 20 mg, magensaftresistente TablettenAmavita Health Care AG
- PolandAnestelocAdamed Pharma S.A.
- PolandAnesteloc 40 mgAdamed Pharma S.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dcbb4316-96ea-475a-a502-8c8dac7d8ad7 GET /v1/drugs/dcbb4316-96ea-475a-a502-8c8dac7d8ad7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki dojelitowe",
"source": "urpl",
"strength": "20 mg",
"packaging": "05909990084999 ¦ Rp ¦ Skasowane ¦ 38894\n14 tabl. w pojemniku\n05909990085002 ¦ Rp ¦ 38895\n28 tabl. w pojemniku\n05909990085026 ¦ Rp ¦ Skasowane ¦ 38896\n14 tabl. w blistrze\n05909990085033 ¦ Rp ¦ 38897\n28 tabl. w blistrze\n05909990664283 ¦ Rp ¦ 45854\n56 tabl.\n05909990817542 ¦ Rp ¦ 61643\n168 tabl.\n05907626701791 ¦ Rp ¦ 84574\n56 tabl.\n05907626702323 ¦ Rp ¦ 84575\n84 tabl.",
"substance": "Pantoprazolum 20 mg",
"common_name": "Pantoprazolum",
"pl_product_id": "100182587",
"pozwolenie_nr": "14294",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about pantoprazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.